Please subscribe using the button below to receive a notification when the material becomes available:

Register for email alerts
 

Publication
  • ASN •
  • 6 November, 2025 •
  • •

Effect of Nanoencapsulated Sirolimus plus Pegadricase (NASP) on Kidney Outcomes: Results from the Phase 3 DISSOLVE Studies

Minesh Rajpal, Vibeke Strand, Rehan Azeem, Ben Peace, Bhavisha Desai, Richard J. Johnson

Publication
  • ASN •
  • 6 November, 2025 •
  • •

Nanoencapsulated Sirolimus Plus Pegadricase (NASP) Reduces Gout Clinical Manifestations in Patients with Uncontrolled Gout (UG) and Stage 3 CKD

Nissreen Elfadawy, Puja Khanna, Rehan Azeem, Ben Peace, Bhavisha Desai, Yasir Qazi

Publication
  • EULAR •
  • 14 June, 2025 •
  • •

Variations in Chronic Refractory Gout Management between Rheumatologists and Nephrologists

Kenneth Saag , Nana Kragh, Amod Athavale, Bhavisha Desai, Amal Gulaid, Abiola Oladapo, Brittany Smith, Hyon Choi

Available materials

Poster
Publication
  • ISPOR •
  • 16 May, 2025 •
  • •

Patient, Caregiver, and Physician Perspectives on the Burden of Disease Chronic Refractory Gout and its Treatment: Concept Elicitation

Angelo Gaffo, Bhavisha Desai, Abiola Oladapo, Nana Kragh, Rebekah Zincavage, Brad Padilla, Naomi Schlesinger

Available materials

Poster
Publication
  • CCR East •
  • 1 May, 2025 •
  • •

Reduction in Tophi Observed in Patients with Chronic Refractory Gout Treated with NASP: Results from Phase 3 DISSOLVE Studies

Herbert Baraf, Puja Khanna, Frédéric Lioté, Rehan Azeem, Wesley DeHaan, Ben Peace , Hugues Santin-Janin, Bhavisha Desai, Alan Kivitz

Available materials

Poster Abstract
Publication
  • CCR East •
  • 1 May, 2025 •
  • •

Nanoencapsulated Sirolimus plus Pegadricase (NASP) Demonstrates a Reduction in Gout Flares: Results from the Phase 3 DISSOLVE Studies

Angelo Gaffo, Herbert Baraf, Anand Patel, Tuhina Neogi, Rehan Azeem, Wesley DeHaan, Ben Peace , Hugues Santin-Janin, Bhavisha Desai, Naomi Schlesinger

Available materials

Poster Abstract
Sign up for alerts